Key result
Aspirin yields multiple extra-cardiovascular therapeutic potencies in facing neurodegenerative disorders, various cancers, inflammatory responses, and the COVID-19 pandemic.
Why the study?
Although the cardiovascular aspects of aspirin are well-established, aspirin has recently been identified to possess multiple extra-cardiovascular therapeutic potencies, prompting an evaluation of its non-cardiovascular roles, particularly in anesthesiology.
Aspirin has broad extra-cardiovascular applications that anesthesiologists must consider during perioperative management.
Answers are grounded in this paper and cite their sources.
Aspirin may have non-cardiovascular benefits; this Level 5 review leaves open the need for randomized trials before clinical adoption.
To the best of our knowledge, aspirin (ASA) is known as a commonly used medication worldwide. Although the cardiovascular aspects of ASA are well-established, recently, it has been identified that ASA can yield multiple extra-cardiovascular therapeutic potencies in facing neurodegenerative disorders, various cancers, inflammatory responses, and the COVID-19 pandemic. In this review, we aimed to highlight the proven role of ASA administration in the variety of non-cardiovascular diseases, particularly in the field of anesthesiology.
No takes yet. Share an insight, caveat, or question.
Rezabakhsh et al. (2021) conducted a review in Extra-cardiovascular diseases. Aspirin was evaluated. Aspirin yields multiple extra-cardiovascular therapeutic potencies in facing neurodegenerative disorders, various cancers, inflammatory responses, and the COVID-19 pandemic.
Synapse has enriched 10 related papers. Consider them for comparative context: